Oppenheimer Asset Management Inc. Has $838,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Oppenheimer Asset Management Inc. lessened its holdings in shares of Humana Inc. (NYSE:HUM) by 83.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 3,302 shares of the insurance provider’s stock after selling 16,345 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Humana were worth $838,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Creative Financial Designs Inc. ADV raised its holdings in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 61 shares in the last quarter. Janney Montgomery Scott LLC raised its holdings in Humana by 11.6% in the 3rd quarter. Janney Montgomery Scott LLC now owns 3,721 shares of the insurance provider’s stock valued at $1,179,000 after acquiring an additional 388 shares in the last quarter. Van ECK Associates Corp acquired a new position in Humana in the 3rd quarter valued at approximately $424,000. Robeco Institutional Asset Management B.V. raised its holdings in Humana by 44.7% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 11,162 shares of the insurance provider’s stock valued at $3,535,000 after acquiring an additional 3,447 shares in the last quarter. Finally, Intact Investment Management Inc. raised its holdings in Humana by 46.3% in the 3rd quarter. Intact Investment Management Inc. now owns 2,780 shares of the insurance provider’s stock valued at $881,000 after acquiring an additional 880 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Up 0.8 %

NYSE:HUM opened at $263.74 on Wednesday. The stock’s fifty day moving average price is $271.40 and its two-hundred day moving average price is $285.08. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $31.82 billion, a price-to-earnings ratio of 26.51, a P/E/G ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Analyst Ratings Changes

HUM has been the subject of several recent research reports. Piper Sandler upped their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Royal Bank of Canada reiterated an “outperform” rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research note on Wednesday. Finally, JPMorgan Chase & Co. lowered their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Twenty investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $285.68.

Insider Activity

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.32% of the stock is currently owned by company insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.